These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33653124)

  • 1. Incident Strokes Among American Indian Individuals With Atrial Fibrillation.
    Sanchez JM; Jolly SE; Dewland TA; Tseng ZH; Nah G; Vittinghoff E; Marcus GM
    J Am Heart Assoc; 2021 Mar; 10(6):e019581. PubMed ID: 33653124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    Kabra R; Girotra S; Vaughan Sarrazin M
    J Am Coll Cardiol; 2016 Aug; 68(5):461-470. PubMed ID: 27470453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study.
    Patel PJ; Katz R; Borovskiy Y; Killian A; Levine JM; McNaughton NW; Callans D; Supple G; Dixit S; Epstein AE; Marchlinski FE; Deo R
    Heart Rhythm; 2018 Apr; 15(4):487-493. PubMed ID: 29475795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
    Shen AY; Chen W; Yao JF; Brar SS; Wang X; Go AS
    CNS Drugs; 2008; 22(10):815-25. PubMed ID: 18788834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
    Golwala H; Jackson LR; Simon DN; Piccini JP; Gersh B; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Fonarow GC; Peterson ED; Thomas KL;
    Am Heart J; 2016 Apr; 174():29-36. PubMed ID: 26995367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites.
    Dewland TA; Olgin JE; Vittinghoff E; Marcus GM
    Circulation; 2013 Dec; 128(23):2470-7. PubMed ID: 24103419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
    Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
    J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.
    Chen ML; Parikh NS; Merkler AE; Kleindorfer DO; Bhave PD; Levitan EB; Soliman EZ; Kamel H
    J Am Heart Assoc; 2019 Feb; 8(4):e010661. PubMed ID: 30741594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences by Race/Ethnicity in the Prevalence of Clinically Detected and Monitor-Detected Atrial Fibrillation: MESA.
    Heckbert SR; Austin TR; Jensen PN; Chen LY; Post WS; Floyd JS; Soliman EZ; Kronmal RA; Psaty BM
    Circ Arrhythm Electrophysiol; 2020 Jan; 13(1):e007698. PubMed ID: 31934795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GY
    Thromb Haemost; 2016 Jan; 115(1):184-92. PubMed ID: 26322338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
    Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
    JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.
    Magnani JW; Norby FL; Agarwal SK; Soliman EZ; Chen LY; Loehr LR; Alonso A
    JAMA Cardiol; 2016 Jul; 1(4):433-41. PubMed ID: 27438320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
    Chao TF; Chen SA; Ruff CT; Hamershock RA; Mercuri MF; Antman EM; Braunwald E; Giugliano RP
    Eur Heart J; 2019 May; 40(19):1518-1527. PubMed ID: 30590425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System.
    Essien UR; Kim N; Hausmann LRM; Mor MK; Good CB; Magnani JW; Litam TMA; Gellad WF; Fine MJ
    JAMA Netw Open; 2021 Jul; 4(7):e2114234. PubMed ID: 34319358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients.
    Tedla YG; Schwartz SM; Silberman P; Greenland P; Passman RS
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104718. PubMed ID: 32122777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.
    Ugowe FE; Jackson LR; Thomas KL
    Heart Rhythm; 2018 Sep; 15(9):1337-1345. PubMed ID: 29803022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of modifiable risk factors for incident atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Shulman E; Chudow JJ; Essien UR; Shanbhag A; Kargoli F; Romero J; Di Biase L; Fisher J; Krumerman A; Ferrick KJ
    Int J Cardiol; 2019 Jan; 275():89-94. PubMed ID: 30340851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Warfarin Anticoagulation in Indigenous and Non-Indigenous Australians With Atrial Fibrillation.
    Nguyen MT; Gallagher C; Pitman BM; Emami M; Kadhim K; Hendriks JM; Middeldorp ME; Roberts-Thomson KC; Mahajan R; Lau DH; Sanders P; Wong CX
    Heart Lung Circ; 2020 Aug; 29(8):1122-1128. PubMed ID: 31980393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Hospital-Documented Atrial Fibrillation and Central Retinal Artery Occlusion.
    Lusk JB; Song A; Unnithan S; Al-Khalidi HR; Delic A; de Havenon A; Biousse V; Schrag M; Poli S; Piccini JP; Xian Y; O'Brien EC; Mac Grory B
    Stroke; 2023 Apr; 54(4):983-991. PubMed ID: 36729390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.
    Shen AY; Yao JF; Brar SS; Jorgensen MB; Wang X; Chen W
    Stroke; 2008 Oct; 39(10):2736-43. PubMed ID: 18635860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.